Feb 18, 2021, 01:00 by User Not Found

Clinical Research News | A Protocol Design Lab (PDL) launched by GlaxoSmithKline (GSK) at the end of 2019 is endeavoring to harness insights from real-world data, clinical trials, and patients themselves to create “operationally viable” protocols linked to predetermined value drivers—notably, clinical studies that are faster and less costly to conduct and include a greater diversity of patients.

Feb 17, 2021, 10:00 by User Not Found

Clinical Research News | Finalists have been named for the 2021 Participant Engagement Award, the industry’s premier effort to highlight creative work in clinical research that helps better engage and understand research participants. Winners will be announced the first week of March at SCOPE, the Summit for Clinical Ops Executives.

Feb 17, 2021, 01:00 by User Not Found

Clinical Research News | One of the bright spots in 2020 is the growth of Decentralized Clinical Trials (DCTs). DCTs are virtual trials that integrate remote assessments with modern digital health technologies, including remote rating apps, wearable monitoring devices, and online social engagement platforms into study design and execution. They were already growing in popularity prior to COVID-19, thanks to regulatory acceptance, trends in clinical practice and the operational/cost efficiencies, but the ongoing global pandemic has accelerated the implementation of DCTs, bringing us to a tipping point.

Feb 16, 2021, 01:00 by User Not Found

Clinical Research News | At the recent COVID-19 and Cancer virtual meeting of the American Association for Cancer Research, the role of the U.S. Food and Drug Administration (FDA) in expediting the development and deployment of a vaccine was the topic of a keynote address by Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research (CBER). His talk focused heavily on a pair of guidance documents issued by the agency last year, including one in October specific to requests for Emergency Use Authorization (EUA) for COVID-19 vaccines.

Feb 15, 2021, 12:27 by

Feb 15, 2021, 12:27 by

Feb 15, 2021, 12:27 by

Feb 15, 2021, 12:27 by

Feb 15, 2021, 12:27 by

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module. The IGX Platform is a professional tool to manage, analyze, integrate, and visualize immune repertoire sequencing data in a single environment. This solution will allow scientists in biopharmaceutical companies and academia, as well as service providers working in the antibody discovery field, to make the most of their Sanger and NGS data and independently perform complex analyses.

Feb 15, 2021, 12:27 by

Scytek laboratories Inc offers Special Stains, Antibodies, Hematology, Microbiology, Hematoxlyn, Scytek Stain Nuclei Histology Red Special Stain, Histology, Nuclear Fast Red Solution, H &E, Eosin, Cytology, Cytoplasm, Collagen, Erythrocytes, DAB Chromogen kit /Substrate Bulk Pack kit Citrate Plus (10x) HIER Solution by scytek

Feb 15, 2021, 12:27 by

Immudex ApS, the sole proprietor of DNA barcoded MHC multimer technology, has announced the launch of dCODE Dextramer® (RiO) — a new reagent compatible with BD Rhapsody™ Single Cell Analysis system for multiplexing, allowing the identification of many different T-cell specificities in the same sample. Creating personalized dCODE Dextramer® libraries, is possible to profile T cells and get a new understanding of T-cell immunity.

Feb 15, 2021, 12:27 by

The elluminate platform now automates clinical operations data workflows with focus on interoperability and analytics for outsourced development models

Feb 15, 2021, 12:27 by

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Feb 15, 2021, 12:27 by

Albumedix Ltd., the world leader in recombinant human albumin, has entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

Feb 15, 2021, 12:27 by

Feb 15, 2021, 12:27 by

Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials

Feb 12, 2021, 01:00 by User Not Found

Clinical Research News | Several promising COVID-19 treatments, majority of Los Angeles healthcare workers not confident about vaccine, patients with dementia at increased risk, pregnancy and vaccination, and AI model predicts risk of death. Plus: old drugs may be repurposed to treat COVID-19, NIH enrolling participants for Phase III clinical trial, New Yorkers more likely to take vaccine than before.

Feb 11, 2021, 01:00 by User Not Found

Clinical Research News | Messenger RNA (mRNA) vaccines were the focus of a symposium on COVID-19 vaccines held during last week’s COVID-19 and Cancer virtual meeting of the American Association for Cancer Research. To date, only two vaccines have received Emergency Use Authorization by the U.S. Food and Drug Administration and both are mRNA vaccines—one developed by Moderna and the other by Pfizer and BioNTech.

Feb 10, 2021, 01:00 by User Not Found

Clinical Research News | In 2020, many companies started prioritizing UX for the first time. And the challenge they are facing includes how to stay agile and make continuous improvements within a remote workforce. This acutely applies to the fields of health data science and software development, where clarity, ease of use, and security are paramount. An improved digital experience informed by an agile approach is one such way that developers can create significant value and deliver on expectations in 2021.

Feb 9, 2021, 01:00 by User Not Found

Clinical Research News | The pilot project of a new HealthJourney program being developed by healthcare social network Inspire is all-virtual recruitment for a clinical research study being conducted in partnership with Pfizer, the Manton Center for Orphan Disease Research at Boston Children’s Hospital (BCH), and Citizen Genetics. The study is endeavoring to identify people in families with a history of autoimmune disease who carry “super-genes,” variants that make them resilient to lung cancer progression